Leadership & Pay ·
On September 4, 2026, BioRestorative Therapies, Inc. received a resignation notice from Mr. Silva, its Vice President…
BRTXBioRestorative Therapies, Inc.
On September 4, 2026, BioRestorative Therapies, Inc. received a resignation notice from Mr. Silva, its Vice President of Research and Development, effective immediately. Silva claims the departure constitutes a resignation for "Good Reason" due to an alleged Change in Control resulting from Board composition changes linked to a June 10, 2026 Revolving Loan Agreement with Bowery Group LLC. He demands approximately $1.29 million in severance, equity acceleration, and benefits. The Company disputes the validity of the Employment Agreement and the Change in Control assertion, reserving all rights while halting payments pending a special counsel investigation into prior executive agreements. BioRestorative Therapies, Inc. operates in the biotechnology industry, focusing on developing cell-based therapies for degenerative diseases.